Veerhealth Care Adjusts Evaluation Score Amid Mixed Technical Indicators and Financial Challenges
Veerhealth Care, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation score, reflecting a change in technical trends. Despite a positive Q1 FY25-26 performance, the company faces challenges with operating losses and low profitability, as indicated by its EBIT to Interest ratio and return on equity.
Veerhealth Care, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical trends associated with the stock, moving from a sideways pattern to a mildly bullish stance. In terms of technical indicators, the MACD shows a mixed outlook, with a mildly bearish signal on a weekly basis and a bullish signal on a monthly basis. The Relative Strength Index (RSI) remains neutral for both weekly and monthly periods, while Bollinger Bands indicate a sideways trend weekly and a bullish trend monthly. Daily moving averages suggest a mildly bullish sentiment.
Despite the recent positive financial performance reported for Q1 FY25-26, the company faces challenges with operating losses and a weak long-term fundamental strength. The EBIT to Interest ratio stands at -0.43, indicating difficulties in servicing debt. Additionally, the return on equity is relatively low at 2.72%, highlighting limited profitability.
The stock has shown varied performance over different time frames, with a notable return of 191.67% over three years, contrasting with a -9.20% return over the past year.
For more insights on Veerhealth Care's financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
